Neutrontherapy in soft tissue sarcomas: a review of European results.

R Schwarz; Andreas Krüll; M Steingräber; A Lessel; R Engenhart; A Favre; N Breteau; F J Prott; T Auberger; R Schmidt

Neutrontherapy in soft tissue sarcomas: a review of European results.

Standard

Neutrontherapy in soft tissue sarcomas: a review of European results. / Schwarz, R; Krüll, Andreas; Steingräber, M; Lessel, A; Engenhart, R; Favre, A; Breteau, N; Prott, F J; Auberger, T; Schmidt, R.

in: Bull Cancer Radiother, Jahrgang 83 Suppl, 1996.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Schwarz, R, Krüll, A, Steingräber, M, Lessel, A, Engenhart, R, Favre, A, Breteau, N, Prott, FJ, Auberger, T & Schmidt, R 1996, 'Neutrontherapy in soft tissue sarcomas: a review of European results.', Bull Cancer Radiother, Jg. 83 Suppl. <http://www.ncbi.nlm.nih.gov/pubmed/8949761?dopt=Citation>

APA

Schwarz, R., Krüll, A., Steingräber, M., Lessel, A., Engenhart, R., Favre, A., Breteau, N., Prott, F. J., Auberger, T., & Schmidt, R. (1996). Neutrontherapy in soft tissue sarcomas: a review of European results. Bull Cancer Radiother, 83 Suppl. http://www.ncbi.nlm.nih.gov/pubmed/8949761?dopt=Citation

Vancouver

Schwarz R, Krüll A, Steingräber M, Lessel A, Engenhart R, Favre A et al. Neutrontherapy in soft tissue sarcomas: a review of European results. Bull Cancer Radiother. 1996;83 Suppl.

Bibtex

@article{229c82b1831c4d30b90f07886ba34001,

title = "Neutrontherapy in soft tissue sarcomas: a review of European results.",

abstract = "The purpose of this publication is to review the data on European neutrontherapy facilities in the treatment of soft tissue sarcoma. Data on 1171 patients treated at 11 centers were analyzed. Neutrontherapy was of advantage especially for patients with primary radiotherapy of inoperable tumors, and those with macroscopic disease after surgery. Local control was about 50% in these groups. Results for postoperative neutrontherapy after R0 and R1 resection were similar to those for photon therapy. The incidence of late side effects was considerable. This was influenced by the fact that most patients were treated with first-generation machines.",

keywords = "Humans, Europe, Longitudinal Studies, Disease-Free Survival, Radiotherapy Dosage, Neoplasm Staging, Sarcoma/mortality/pathology/*radiotherapy, *Fast Neutrons, Photons, *Radiotherapy, High-Energy/adverse effects/methods, Soft Tissue Neoplasms/mortality/pathology/*radiotherapy, Humans, Europe, Longitudinal Studies, Disease-Free Survival, Radiotherapy Dosage, Neoplasm Staging, Sarcoma/mortality/pathology/*radiotherapy, *Fast Neutrons, Photons, *Radiotherapy, High-Energy/adverse effects/methods, Soft Tissue Neoplasms/mortality/pathology/*radiotherapy",

author = "R Schwarz and Andreas Kr{\"u}ll and M Steingr{\"a}ber and A Lessel and R Engenhart and A Favre and N Breteau and Prott, {F J} and T Auberger and R Schmidt",

year = "1996",

language = "English",

volume = "83 Suppl",

}

RIS

TY - JOUR

T1 - Neutrontherapy in soft tissue sarcomas: a review of European results.

AU - Schwarz, R

AU - Krüll, Andreas

AU - Steingräber, M

AU - Lessel, A

AU - Engenhart, R

AU - Favre, A

AU - Breteau, N

AU - Prott, F J

AU - Auberger, T

AU - Schmidt, R

PY - 1996

Y1 - 1996

N2 - The purpose of this publication is to review the data on European neutrontherapy facilities in the treatment of soft tissue sarcoma. Data on 1171 patients treated at 11 centers were analyzed. Neutrontherapy was of advantage especially for patients with primary radiotherapy of inoperable tumors, and those with macroscopic disease after surgery. Local control was about 50% in these groups. Results for postoperative neutrontherapy after R0 and R1 resection were similar to those for photon therapy. The incidence of late side effects was considerable. This was influenced by the fact that most patients were treated with first-generation machines.

AB - The purpose of this publication is to review the data on European neutrontherapy facilities in the treatment of soft tissue sarcoma. Data on 1171 patients treated at 11 centers were analyzed. Neutrontherapy was of advantage especially for patients with primary radiotherapy of inoperable tumors, and those with macroscopic disease after surgery. Local control was about 50% in these groups. Results for postoperative neutrontherapy after R0 and R1 resection were similar to those for photon therapy. The incidence of late side effects was considerable. This was influenced by the fact that most patients were treated with first-generation machines.

KW - Humans

KW - Europe

KW - Longitudinal Studies

KW - Disease-Free Survival

KW - Radiotherapy Dosage

KW - Neoplasm Staging

KW - Sarcoma/mortality/pathology/radiotherapy

KW - Fast Neutrons

KW - Photons

KW - Radiotherapy, High-Energy/adverse effects/methods

KW - Soft Tissue Neoplasms/mortality/pathology/radiotherapy